High Granular Tick Data API: US Stocks Learn more

Prestige BioPharma Limited (950210 KO) stock market data APIs

₩12047.9132 77.11(0.6%)
as of January 16, 2026
Try our APIs with free plan!

Prestige BioPharma Limited Financial Data Overview

Price chart is built with Anychart
ISIN: KR870207**** The data is available with plans that include the Fundamentals API. Check our pricing page for details.

Prestige BioPharma Limited, a biopharmaceutical company, engages in the research and development and marketing of biosimilars, first-in-class antibody drugs, and vaccines in Singapore. The company's approved product is Trastuzumab Biosimilar for treatment the of early breast cancer, metastatic breast cancer, and metastatic gastric cancer. In addition, its pipeline includes Adalimumab, which is in phase 1 trial for arthritis; and Bevacizumab, in phase 3 clinical study for non-small cell lung cancer, colorectal cancer. It is also developing diagnostic kits for the detection of pancreatic adenocarcinoma upregulated factor. Prestige BioPharma Limited was incorporated in 2015 and is headquartered in Singapore.

Prev. Close 12047.9132
Open 12125.0241
High 12197.7233
Low 11932.1204
52 wk Range 11910-14120
Market Cap 781 250 M
Shares Outstanding 60 096 K
Revenue 14 412 M
Beta 0.972

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Prestige BioPharma Limited data using free add-ons & libraries


Get Prestige BioPharma Limited Fundamental Data

Prestige BioPharma Limited Fundamental data includes:

  • Net Revenue: 14 412 M
  • EBITDA: -52 163 551 232
  • Earnings Per Share:
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Prestige BioPharma Limited Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: NaN
  • EPS/Forecast: NaN
GET THE PACKAGE

Get Prestige BioPharma Limited End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE
Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat

Send the request

Leave your email and our team will contact you ASAP.